Editas Medicine Market Sentiment

SPY768.81+0.73%QQQ722.19+1.75%BTC/USD—DIA519.56+0.09%GLD380.02−0.52%TLT79.65−0.50%

Premium

Editas Medicine Inc

EDITNASDAQ

Trade with Public

$2.35

0.0050.21%

Last update: Oct 19, 11:16 AM

$2.37

0.0150.64%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Editas Medicine Market Sentiment - Benzinga

Editas Medicine Market Sentiment

Market sentiment signals for Editas Medicine (EDIT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 24.2% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

18 analysts

Options Flow (P/C)

—

Avg Consensus PT

+187.0%

Highest Price Target

$15

+536.9%

Citigroup

Lowest Price Target

+27.4%

HC Wainwright & Co.

Short Interest

24.2%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	Wells Fargo	Yanan Zhu—	+154.8%	$4 → $6	Upgrade	Equal-Weight→Overweight
Sep 23, 2026	Guggenheim	Debjit Chattopadhyay—	+112.3%	$5	Upgrade	Neutral→Buy
Aug 18, 2026	Ladenburg Thalmann	——	+154.8%	$6	Initiate	Buy
May 5, 2026	Chardan Capital	Geulah Livshits—	+69.9%	$4 → $4	Maintained	Buy
Mar 10, 2026	Jones Trading	Soumit Roy—	+239.7%	$8	Upgrade	Hold→Buy
Mar 9, 2026	Chardan Capital	Geulah Livshits—	+48.6%	$4 → $4	Maintained	Buy
Sep 5, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+112.3%	$5 → $5	Maintained	Buy
Sep 3, 2025	Wells Fargo	Yanan Zhu—	+69.9%	$3 → $4	Maintained	Equal-Weight
Aug 15, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+112.3%	$3 → $5	Maintained	Buy
Aug 13, 2025	Baird	Joel Beatty—	+154.8%	$4 → $6	Maintained	Outperform
May 13, 2025	Baird	Joel Beatty—	+69.9%	$8 → $4	Maintained	Outperform
Apr 28, 2025	HC Wainwright & Co.	Mitchell Kapoor—	+27.4%	$3	Initiate	Buy
Dec 16, 2024	Evercore ISI Group	Liisa Bayko—	+112.3%	$7 → $5	Maintained	Outperform
Dec 16, 2024	JP Morgan	Brian Cheng—	—	—	Downgrade	Neutral→Underweight
Dec 13, 2024	RBC Capital	Luca Issi—	+69.9%	$5 → $4	Maintained	Sector Perform
Dec 13, 2024	Barclays	Gena Wang—	+27.4%	$5 → $3	Maintained	Equal-Weight
Dec 13, 2024	Chardan Capital	Geulah Livshits—	—	—	Downgrade	Buy→Neutral
Dec 13, 2024	Baird	Joel Beatty—	+239.7%	$10 → $8	Maintained	Outperform
Dec 13, 2024	Stifel	Dae Gon Ha—	+27.4%	$11 → $3	Downgrade	Buy→Hold
Dec 11, 2024	Wells Fargo	Yanan Zhu—	+69.9%	$7 → $4	Downgrade	Overweight→Equal-Weight
Nov 5, 2024	Chardan Capital	Geulah Livshits—	+409.6%	$12 → $12	Maintained	Buy
Nov 5, 2024	RBC Capital	Luca Issi—	+112.3%	$8 → $5	Maintained	Sector Perform
Nov 5, 2024	Stifel	Dae Gon Ha—	+367.1%	$17 → $11	Maintained	Buy
Nov 5, 2024	Truist Securities	Joon Lee—	+239.7%	$12 → $8	Maintained	Buy
Nov 5, 2024	Wells Fargo	Yanan Zhu—	+197.2%	$9 → $7	Maintained	Overweight